sotalol has been researched along with Cancer of Prostate in 2 studies
Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.
Excerpt | Relevance | Reference |
---|---|---|
"The study included all new prostate cancer cases diagnosed in Finland during 1995-2002 and matched controls (24,657 case-control pairs) obtained from the Finnish Cancer Registry and the Population Register Center, respectively." | 1.42 | Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population-based case-control study. ( Ahti, J; Auvinen, A; Kaapu, KJ; Murtola, TJ; Tammela, TL, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaapu, KJ | 2 |
Ahti, J | 1 |
Tammela, TL | 2 |
Auvinen, A | 2 |
Murtola, TJ | 2 |
Määttänen, L | 1 |
Talala, K | 1 |
Taari, K | 1 |
2 other studies available for sotalol and Cancer of Prostate
Article | Year |
---|---|
Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population-based case-control study.
Topics: Anti-Arrhythmia Agents; Case-Control Studies; Digoxin; Finland; Humans; Logistic Models; Male; Potas | 2015 |
Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Cohort Studies; Digoxin; Finland; Humans; | 2016 |